

Scientists have enrolled the first patient in a groundbreaking trial to find effective treatments for the deadly Bundibugyo strain of Ebola in the Democratic Republic of Congo.

The trial brings hope to a region where more than 1,400 people have been infected since May, with currently no approved treatments available.

Want to know more?